rs2177153

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001457.4(FLNB):​c.1748-61A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.292 in 1,502,124 control chromosomes in the GnomAD database, including 68,185 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.29 ( 6787 hom., cov: 31)
Exomes 𝑓: 0.29 ( 61398 hom. )

Consequence

FLNB
NM_001457.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0340

Publications

12 publications found
Variant links:
Genes affected
FLNB (HGNC:3755): (filamin B) This gene encodes a member of the filamin family. The encoded protein interacts with glycoprotein Ib alpha as part of the process to repair vascular injuries. The platelet glycoprotein Ib complex includes glycoprotein Ib alpha, and it binds the actin cytoskeleton. Mutations in this gene have been found in several conditions: atelosteogenesis type 1 and type 3; boomerang dysplasia; autosomal dominant Larsen syndrome; and spondylocarpotarsal synostosis syndrome. Multiple alternatively spliced transcript variants that encode different protein isoforms have been described for this gene. [provided by RefSeq, Nov 2009]
FLNB Gene-Disease associations (from GenCC):
  • atelosteogenesis type I
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • atelosteogenesis type III
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • Larsen syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • spondylocarpotarsal synostosis syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • Boomerang dysplasia
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 3-58106619-A-G is Benign according to our data. Variant chr3-58106619-A-G is described in ClinVar as Benign. ClinVar VariationId is 675060.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.326 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001457.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FLNB
NM_001457.4
MANE Select
c.1748-61A>G
intron
N/ANP_001448.2
FLNB
NM_001164317.2
c.1748-61A>G
intron
N/ANP_001157789.1
FLNB
NM_001164318.2
c.1748-61A>G
intron
N/ANP_001157790.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FLNB
ENST00000295956.9
TSL:1 MANE Select
c.1748-61A>G
intron
N/AENSP00000295956.5
FLNB
ENST00000490882.5
TSL:1
c.1748-61A>G
intron
N/AENSP00000420213.1
FLNB
ENST00000429972.6
TSL:1
c.1748-61A>G
intron
N/AENSP00000415599.2

Frequencies

GnomAD3 genomes
AF:
0.289
AC:
43843
AN:
151836
Hom.:
6766
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.330
Gnomad AMI
AF:
0.136
Gnomad AMR
AF:
0.215
Gnomad ASJ
AF:
0.388
Gnomad EAS
AF:
0.0223
Gnomad SAS
AF:
0.183
Gnomad FIN
AF:
0.247
Gnomad MID
AF:
0.383
Gnomad NFE
AF:
0.311
Gnomad OTH
AF:
0.299
GnomAD4 exome
AF:
0.293
AC:
395180
AN:
1350170
Hom.:
61398
AF XY:
0.292
AC XY:
197661
AN XY:
677960
show subpopulations
African (AFR)
AF:
0.343
AC:
10663
AN:
31092
American (AMR)
AF:
0.160
AC:
7129
AN:
44464
Ashkenazi Jewish (ASJ)
AF:
0.386
AC:
9810
AN:
25396
East Asian (EAS)
AF:
0.0159
AC:
622
AN:
39154
South Asian (SAS)
AF:
0.214
AC:
17938
AN:
83914
European-Finnish (FIN)
AF:
0.246
AC:
13093
AN:
53194
Middle Eastern (MID)
AF:
0.371
AC:
2070
AN:
5578
European-Non Finnish (NFE)
AF:
0.314
AC:
316926
AN:
1010692
Other (OTH)
AF:
0.299
AC:
16929
AN:
56686
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
13780
27561
41341
55122
68902
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9786
19572
29358
39144
48930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.289
AC:
43902
AN:
151954
Hom.:
6787
Cov.:
31
AF XY:
0.284
AC XY:
21085
AN XY:
74260
show subpopulations
African (AFR)
AF:
0.331
AC:
13690
AN:
41406
American (AMR)
AF:
0.215
AC:
3282
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.388
AC:
1348
AN:
3470
East Asian (EAS)
AF:
0.0222
AC:
115
AN:
5184
South Asian (SAS)
AF:
0.184
AC:
882
AN:
4800
European-Finnish (FIN)
AF:
0.247
AC:
2609
AN:
10562
Middle Eastern (MID)
AF:
0.398
AC:
117
AN:
294
European-Non Finnish (NFE)
AF:
0.311
AC:
21097
AN:
67938
Other (OTH)
AF:
0.302
AC:
638
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1559
3119
4678
6238
7797
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
434
868
1302
1736
2170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.306
Hom.:
25332
Bravo
AF:
0.289
Asia WGS
AF:
0.115
AC:
404
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
1.2
DANN
Benign
0.34
PhyloP100
0.034
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2177153; hg19: chr3-58092346; API